Såranalyse.dk ApS: Financial statements 2022
CVR: 32661971
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Såranalyse.dk ApS (CVR 32661971) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,457 and a net result of DKK -22,820 compared with DKK -11,396 the year before. Equity in the 2022 report amounted to DKK 229,903. The solvency ratio was 56.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -7,457
- Profit/Loss
- DKK -22,820
- Equity
- DKK 229,903
- Total Assets
- DKK 405,433
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -7 t. | -23 t. | 230 t. | - |
| 2021 | - | -7 t. | -11 t. | 253 t. | - |
| 2020 | - | -9 t. | -2 t. | 264 t. | - |
| 2019 | - | -6 t. | 3 t. | 266 t. | - |
| 2018 | - | -7 t. | -9 t. | 263 t. | - |
Official annual report
Keep an eye on Såranalyse.dk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Såranalyse.dk ApS has published its annual report for 2021. Gross profit came to DKK -6,638, and the net result was DKK -11,396.
About Såranalyse.dk ApS
Såranalyse.dk ApS was a Danish company of the type Anpartsselskab based in Ugerløse, founded in 2009. The company has been dissolved on 10 August 2026. The company was registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named SUSAN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,744 and a net result of DKK -297,616 compared with DKK -2,153 the year before. Equity in the 2025 report amounted to DKK -72,959.